Dermatology · Rockville, MD
NPI
1730188475
Since 2005
Specialty
Dermatology
Code 207N00000X
Group practices
2
Medicare group memberships
Hospitals
0
Hospital affiliations
15245 Shady Grove Rd Ste 370
Rockville, MD, 20850
Phone (240) 246-7417
Groups this clinician bills Medicare through
Medicare paid, 2024
$465K
10,059 services
Medicare patients, 2024
1,642
Average age 75
Drug cost, 2024
$607K
1,354 prescriptions
Company payments, 2025
$968
From 16 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Josef K Yeager was code 17003 (destruction skin lesion), 4,191 times for 743 patients. In total Josef K Yeager billed 10,059 services in 37 codes, and Medicare paid $465K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-08-06.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 17003 Destruction Skin Lesion | Office | 4,191 | 743 | $5.63 | $24K |
| 99214 Office E&M - Established | Office | 1,891 | 1,194 | $104.88 | $198K |
| 17000 Destruction Skin Lesion | Office | 1,558 | 931 | $43.52 | $68K |
| 11102 Skin Biopsy | Office | 965 | 732 | $75.68 | $73K |
| 11103 Skin Biopsy | Office | 304 | 209 | $42.45 | $13K |
| 99213 Office E&M - Established | Office | 245 | 232 | $65.47 | $16K |
| 17110 Destruction Skin Lesion | Office | 242 | 199 | $88.53 | $21K |
| 99212 Office E&M - Established | Office | 205 | 185 | $45.16 | $9,257 |
| 99203 Office E&M - New | Office | 121 | 121 | $89.65 | $11K |
| 17004 Destruction Skin Lesion | Office | 66 | 49 | $139.35 | $9,197 |
| 99202 Office E&M - New | Office | 60 | 60 | $50.36 | $3,022 |
| 69100 Other Organ Systems | Office | 54 | 47 | $59.47 | $3,211 |
| 10060 Skin | Office | 31 | 30 | $107.73 | $3,340 |
| 17262 Destruction Skin Lesion | Office | 26 | 23 | $158.26 | $4,115 |
| 11104 Skin Biopsy | Office | 25 | 25 | $97.04 | $2,426 |
By year: 2022 $370K for 8,492 services; 2023 $459K for 10,135 services; 2024 $465K for 10,059 services.
Medicare prescription drug claims, 2024
In 2024, the drug Josef K Yeager prescribed most often to Medicare patients was Metronidazole, with 303 prescriptions and refills. In total Josef K Yeager wrote 1,354 Medicare prescriptions that cost $607K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Metronidazole Generic | 303 | 360 | 158 | $14K |
| Triamcinolone Acetonide Generic | 127 | 163 | 90 | $1,040 |
| Ketoconazole Generic | 126 | 152 | 66 | $2,572 |
| Fluocinonide Generic | 107 | 113 | 76 | $5,068 |
| Clobetasol Propionate Generic | 68 | 75 | 42 | $4,423 |
| Doxycycline Hyclate Generic | 56 | 86 | 35 | $859 |
| Mupirocin Generic | 44 | 44 | 38 | $397 |
| Dupixent Pen Dupilumab | 35 | 47 | Under 11 | $188K |
| Clindamycin Phosphate Generic | 30 | 33 | 18 | $1,431 |
| Valacyclovir Valacyclovir Hcl | 27 | 37 | 16 | $700 |
| Fluorouracil Generic | 26 | 27 | 24 | $1,404 |
| Clotrimazole-Betamethasone Clotrimazole/Betamethasone Dip | 25 | 26 | 18 | $436 |
| Hydroxyzine Hcl Generic | 24 | 24 | Under 11 | $114 |
| Otezla Apremilast | 21 | 21 | Under 11 | $104K |
| Azelaic Acid Generic | 20 | 29 | Under 11 | $1,365 |
Brand drugs: 246 claims; generic drugs: 1,108 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Josef K Yeager $968 ($968 in general payments such as food, travel and fees) from 16 companies. The largest payer was Genzyme Corporation with $173.
| Company | Payments | Amount |
|---|---|---|
| Genzyme Corporation SNY | 4 | $173 |
| Abbvie Inc. ABBV | 10 | $166 |
| Pfizer Inc. PFE | 5 | $125 |
| UCB, Inc. UCB.BR | 3 | $68.61 |
| Novartis Pharmaceuticals Corporation NVS | 3 | $67 |
| Incyte Corporation INCY | 2 | $56.32 |
| Janssen Biotech, Inc. JNJ | 2 | $56.07 |
| Galderma Laboratories, L.P. GALD.SW | 2 | $40.08 |
| Lilly USA, LLC LLY | 2 | $37.83 |
| Organon LLC OGN | 3 | $36.28 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.